South Dakota Codified Laws 36-11A-4.2. Prior registration and inspection by FDA required for certain outsourcing facilities
Current as of: 2023 | Check for updates
|
Other versions
No outsourcing facility engaged in compounding of nonpatient specific sterile and nonsterile drugs may become licensed by the board without first obtaining a registration and inspection by the United States Food and Drug Administration, and paying the license fee set by the board in rules promulgated pursuant to chapter 1-26. The fee may not exceed two hundred dollars.
Source: SL 2017, ch 174, § 8.